Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Medicine, Hematology and Medical Oncology
Biography
Dr. Tiersten is a Professor in the Division of Hematology and Medical Oncology and a member of the Breast Cancer Medical Oncology Program. Dr. Tiersten sees patients in the Dubin Breast Center. She works collaboratively with Mount Sinai breast surgeons, radiation oncologists, radiologists, and other related subspecialists to provide care to breast cancer patients and conduct breast cancer research. Dr. Tiersten has extensive experience participating clinical trials, as well as being the Principal Investigator for national studies.
Fingerprint
Dive into the research topics where Amy Tiersten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors
Montgomery, G. H., Schnur, J. B., Tiersten, A., Benck, K. & Erblich, J., 2024, (Accepted/In press) In: Psychology of Consciousness: Theory Research, and Practice.Research output: Contribution to journal › Article › peer-review
-
Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS)
Casasanta, N., Patel, R., Raymond, S., Kier, M. W., Blanter, J., Sohval, S., Hovstadius, M., Wu, C., Zimmerman, B., Cascetta, K., Bagiella, E. & Tiersten, A., Oct 2024, In: Clinical Breast Cancer. 24, 7, p. 585-596 12 p.Research output: Contribution to journal › Article › peer-review
-
Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial
Ma, C. X., Suman, V. J., Sanati, S., Vij, K., Anurag, M., Leitch, A. M., Unzeitig, G. W., Hoog, J., Fernandez-Martinez, A., Fan, C., Gibbs, R. A., Watson, M. A., Dockter, T. J., Hahn, O., Guenther, J. M., Caudle, A., Crouch, E., Tiersten, A., Mita, M. & Razaq, W. & 10 others, , 21 Mar 2024, In: JAMA Oncology. 10, 3, p. 362-371 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression
Kessler, A. J., Patel, R., Gallagher, E. J., Sheng, T., Mendu, D. R., Tiersten, A., Klein, P., Bhardwaj, A. S., Goel, A., Sparano, J. A., Shao, T. & Fasano, J., Oct 2024, In: Breast Cancer Research and Treatment. 207, 3, p. 529-532 4 p.Research output: Contribution to journal › Article › peer-review
-
Patterns in use and tolerance of adjuvant neratinib in patients with hormone receptor (HR)-positive, HER2-positive early-stage breast cancer
Blanter, J., Baldwin, E., Patel, R., Sheng, T. & Tiersten, A., Nov 2024, In: Breast Cancer Research and Treatment. 208, 2, p. 461-466 6 p.Research output: Contribution to journal › Article › peer-review
Press/Media
-
New Findings in Kinase Inhibitors Described from Icahn School of Medicine at Mount Sinai (Monitoring of Estradiol Levels In Premenopausal Women Receiving Adjuvant Abemaciclib and Ovarian Function Suppression)
Goel, A., Sparano, J., Klein, P., Bhardwaj, A., Tiersten, A., Gallagher, E. & Fasano, J.
2/09/24
1 item of Media coverage
Press/Media